← Browse by Condition
Medical Condition

x linked retinoschisis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05878860 Phase 1, Phase 2
Recruiting

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

Enrollment
21 pts
Location
United States
Sponsor
Atsena Therapeutics Inc.
View Trial →